Sigachi Industries has informed that pursuant to the Company's Code of Conduct for Prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will remain closed for ‘Designated Persons and their immediate relatives’ from Thursday, January 01, 2026 till Forty Eight hours after the dissemination of the unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended December 31, 2025. The Board Meeting will be scheduled, inter-alia, to consider and approve the unaudited Financial Results for the quarter ended December 31, 2025. Accordingly, an intimation regarding the notice of Board Meeting shall be sent separately to the Stock Exchanges. Further, the designated persons and their immediate relatives have been intimated not to trade in the securities of the Company during the above said period of closure of trading window.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: